Enriched Chicken Bone Broth as a Dietary Supplement Reduces Nociception and Sensitization Associated with Prolonged Jaw Opening

Aims: To test a commercially available enriched chicken bone broth (ECBB) product for its potential anti-inflammatory properties and to evaluate its ability to reduce nociception and expression of protein kinase A (PKA) in a clinically relevant model of temporomandibular disorder (TMD) caused by prolonged jaw opening in rats. Methods: The potential of the ECBB and of a homemade broth was investigated using the Folin–Ciocalteu reagent and percent inhibition of cyclooxygenase-2 (COX-2) activity, which was determined using a commercially available kit. Additionally, the effect of ECBB and homemade broth on nocifensive head withdrawal responses to mechanical stimulation in male Sprague-Dawley rats subjected to prolonged jaw opening was evaluated. Differences were considered significant at P < .025. Changes in PKA expression in the medullary dorsal horn region of the spinal trigeminal nucleus associated with prolonged jaw opening were assessed using immunofluorescence, and these changes were considered significant at P < .05. Behavioral data were analyzed by using multiple nonparametric tests, and immunohistochemistry data were analyzed by using one-way analysis of variance with Games-Howell post hoc tests in SPSS software. Results: ECBB exhibited greater reducing potential and inhibition of COX-2 activity compared to homemade broth. Near maximal jaw opening was sufficient to induce sustained nocifensive responses to mechanical stimuli for 7 days. This increased sensitivity was correlated with elevated levels of the active form of PKA. Importantly, dietary inclusion of ECBB, but not of homemade broth, for 2 weeks prior to jaw opening was sufficient to reduce nocifensive behaviors and PKA expression. Conclusion: Findings from this study provide evidence that ECBB attenuates nociception and expression of the pro-inflammatory protein PKA and thus may be beneficial as a nutraceutical supplement to manage inflammatory pain associated with TMD.

antioxidant;joint;temporomandibular disorder;trigeminal

1.Furquim BD, Flamengui LM, Conti PC. TMD and chronic pain: A current view. Dental Press J Orthod 2015;20:127–133.

2.Greenspan JD, Slade GD, Bair E, et al. Pain sensitivity risk fac-tors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case control study. J Pain 2011; 12(suppl):T61–T74.

3.Ohrbach R, Fillingim RB, Mulkey F, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: Descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011;12(suppl):T27–T45.

4.Sessle BJ. Peripheral and central mechanisms of orofacial inflam-matory pain. Int Rev Neurobiol 2011;97:179–206.

5.Appelgren A, Appelgren B, Kopp S, Lundeberg T, Theodorsson E. Neuropeptides in the arthritic TMJ and symptoms and signs from the stomatognathic system with special consideration to rheumatoid arthritis. J Orofac Pain 1995;9:215–225.

6.Cady RJ, Glenn JR, Smith KM, Durham PL. Calcitonin gene-related peptide promotes cellular changes in trigeminal neurons and glia implicated in peripheral and central sensitiza-tion. Mol Pain 2011;7:94.

7.Durham PL. Diverse physiological roles of calcitonin gene-related peptide in migraine pathology: Modulation of neuronal-glial-immune cells to promote peripheral and central sensitization. Curr Pain Headache Rep 2016;20:48.

8.Seybold VS. The role of peptides in central sensitization. Handb Exp Pharmacol 2009;(194):451–491.

9.Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related pep-tide (CGRP) and migraine current understanding and state of de-velopment. Headache 2013;53:1230–1244.

10.Romero-Reyes M, Pardi V, Akerman S. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain. Exp Neurol 2015;271:95–103.

11.Tjakkes GH, Reinders JJ, Tenvergert EM, Stegenga B. TMD pain: The effect on health related quality of life and the influence of pain duration. Health Qual Life Outcomes 2010;8:46.

12.Romero-Reyes M, Uyanik JM. Orofacial pain management: Current perspectives. J Pain Res 2014;7:99–115.

13.Wieckiewicz M, Boening K, Wiland P, Shiau YY, Paradowska-Stolarz A. Reported concepts for the treatment modalities and pain management of temporomandibular disorders. J Headache Pain 2015;16:106.

14.Rosner F. Therapeutic efficacy of chicken soup. Chest 1980; 78:672–674.

15.Rosner F. Medical writings of Moses Maimonides. N Y State J Med 1973;73:2186–2189.

16.Saketkhoo K, Januszkiewicz A, Sackner MA. Effects of drinking hot water, cold water, and chicken soup on nasal mucus velocity and nasal airflow resistance. Chest 1978;74:408–410.

17.Rennard BO, Ertl RF, Gossman GL, Robbins RA, Rennard SI. Chicken soup inhibits neutrophil chemotaxis in vitro. Chest 2000;118:1150–1157.

18.Lee KW, Kim YJ, Lee HJ, Lee CY. Cocoa has more phenolic phy-tochemicals and a higher antioxidant capacity than teas and red wine. J Agric Food Chem 2003;51:7292–7295.

19.Abbey MJ, Patil VV, Vause CV, Durham PL. Repression of calci-tonin gene-related peptide expression in trigeminal neurons by a Theobroma cacao extract. J Ethnopharmacol 2008;115:238–248.

20.Cornelison LE, Hawkins JL, Durham PL. Elevated levels of calci-tonin gene-related peptide in upper spinal cord promotes sensi-tization of primary trigeminal nociceptive neurons. Neuroscience 2016;339:491–501.

21.Hawkins JL, Durham PL. Prolonged jaw opening promotes no-ciception and enhanced cytokine expression. J Oral Facial Pain Headache 2016;30:34–41.

22.Garrett FG, Hawkins JL, Overmyer AE, Hayden JB, Durham PL. Validation of a novel rat-holding device for studying heat- and mechanical-evoked trigeminal nocifensive behavioral responses. J Orofac Pain 2012;26:337–344.

23.Hawkins JL, Denson JE, Miley DR, Durham PL. Nicotine stimu-lates expression of proteins implicated in peripheral and central sensitization. Neuroscience 2015;290:115–125.

24.Cady RJ, Durham PL. Cocoa-enriched diets enhance expres-sion of phosphatases and decrease expression of inflammato-ry molecules in trigeminal ganglion neurons. Brain Res 2010; 1323:18–32.

25.Alasalvar C, Bolling BW. Review of nut phytochemicals, fat-soluble bioactives, antioxidant components and health ef-fects. Br J Nutr 2015;113(suppl):s68–s78.

26.Cady RJ, Hirst JJ, Durham PL. Dietary grape seed polyphenols repress neuron and glia activation in trigeminal ganglion and tri-geminal nucleus caudalis. Mol Pain 2010;6:91.

27.Cady RJ, Denson JE, Durham PL. Inclusion of cocoa as a dietary supplement represses expression of inflammatory proteins in spinal trigeminal nucleus in response to chronic trigeminal nerve stimulation. Mol Nutr Food Res 2013;57:996–1006.

28.Sekiguchi K, Takehana S, Shibuya E, et al. Resveratrol attenu-ates inflammation-induced hyperexcitability of trigeminal spinal nucleus caudalis neurons associated with hyperalgesia in rats. Mol Pain 2016;12.

29.Consalvi S, Biava M, Poce G. COX inhibitors: A patent review (2011 - 2014). Expert Opin Ther Pat 2015;25:1357–1371.

30.Levy D, Zhang XC, Jakubowski M, Burstein R. Sensitization of meningeal nociceptors: Inhibition by naproxen. Eur J Neurosci 2008;27:917–922.

31.Zhang XC, Kainz V, Burstein R, Levy D. Tumor necrosis fac-tor-alpha induces sensitization of meningeal nociceptors me-diated via local COX and p38 MAP kinase actions. Pain 2011; 152:140–149.

32.Satoh K, Ogura N, Akutsu M, et al. Expression of cyclo-oxygenase-1 and -2 in IL-1beta-induced synovitis of the tem-poromandibular joint. J Oral Pathol Med 2009;38:584–590.

33. Basi DL, Velly AM, Schiffman EL, et al. Human temporomandibu-lar joint and myofascial pain biochemical profiles: A case-control study. J Oral Rehabil 2012;39:326–337.

34.Sun RQ, Tu YJ, Lawand NB, Yan JY, Lin Q, Willis WD. Calcitonin gene-related peptide receptor activation produces PKA- and PKC-dependent mechanical hyperalgesia and central sensitiza-tion. J Neurophysiol 2004;92:2859–2866.

35.Schuh CD, Brenneis C, Zhang DD, et al. Prostacyclin regu-lates spinal nociceptive processing through cyclic adenosine monophosphate-induced translocation of glutamate receptors. Anesthesiology 2014;120:447–458.

36.Meves H. The action of prostaglandins on ion channels. Curr Neuropharmacol 2006;4:41–57.